IDENTIFICATION AND QUANTIFICATION OF THE INDOLE ALKALOID IBOGAINE IN BIOLOGICAL SAMPLES BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY

被引:24
作者
GALLAGHER, CA
HOUGH, LB
KEEFNER, SM
SEYEDMOZAFFARI, A
ARCHER, S
GLICK, SD
机构
[1] ALBANY MED COLL,DEPT PHARMACOL & TOXICOL A136,ALBANY,NY 12208
[2] RENSSELAER POLYTECH INST,DEPT CHEM,TROY,NY 12180
[3] CAPITAL DIST CTR DRUG ABUSE RES & TREATMENT,ALBANY,NY 12208
关键词
IBOGAINE; DRUG ABUSE; QUANTITATIVE ANALYSIS; ANALYTICAL CHEMISTRY; BRAIN; GAS CHROMATOGRAPHY MASS SPECTROMETRY;
D O I
10.1016/0006-2952(94)00441-N
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A sensitive and highly selective analytical chemical method for measuring the indole alkaloid ibogaine in biological samples has been developed. The method utilizes organic extraction, derivatization with trifluoroacetic anhydride, and detection by combined gas chromatography-mass spectrometry. The deuterated analog of ibogaine, O-[Cd-3]-ibogaine, was synthesized and used as an internal standard for the method. Standard curves, constructed from variable amounts of ibogaine (50-400 ng) and a fixed amount of internal standard (250 ng) were linear. The method has an approximate detection limit of at least 20 ng/mL of tissue extract (180 ng/g tissue), with a coefficient of variation of 8 to 12.5%. Chemical stability studies with the method found that aqueous ibogaine solutions (1-10 mg/mL) could be stored at 10 degrees for up to 7 months with no more than 10% loss. The method was also used to measure brain ibogaine levels in rats 1 and 19 hr after a single dose of drug (40 mg/kg, i.p.); the results suggest a rapid disappearance of the drug after i.p. dosing. The method will help reveal the pharmacokinetic properties of this putative anti-addictive agent in animals and humans.
引用
收藏
页码:73 / 79
页数:7
相关论文
共 12 条
[1]   DETECTION OF IBOGAINE IN ORGANIC LIQUIDS [J].
BERTOL, E ;
MARI, F ;
FROLDI, R .
JOURNAL OF CHROMATOGRAPHY, 1976, 117 (01) :239-241
[2]   APPLICATION OF MASS SPECTROMETRY TO STRUCTURE PROBLEMS .5. IBOGA ALKALOIDS [J].
BIEMANN, K ;
FRIEDMANN, M .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1961, 83 (23) :4805-&
[3]   INHIBITORY EFFECTS OF IBOGAINE ON COCAINE SELF-ADMINISTRATION IN RATS [J].
CAPPENDIJK, SLT ;
DZOLJIC, MR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 241 (2-3) :261-265
[4]   GAS-CHROMATOGRAPHIC DETERMINATION OF IBOGAINE IN BIOLOGICAL-FLUIDS [J].
CARTONI, GP ;
GIARUSSO, A .
JOURNAL OF CHROMATOGRAPHY, 1972, 71 (01) :154-&
[5]  
COSTA E, 1975, HDB PSYCHOPHARMACOLO, P1
[6]   MECHANISMS OF ACTION OF IBOGAINE AND HARMALINE CONGENERS BASED ON RADIOLIGAND BINDING-STUDIES [J].
DEECHER, DC ;
TEITLER, M ;
SODERLUND, DM ;
BORNMANN, WG ;
KUEHNE, ME ;
GLICK, SD .
BRAIN RESEARCH, 1992, 571 (02) :242-247
[7]  
Dhahir HI, 1971, THESIS INDIANA U IND
[8]   EFFECTS AND AFTEREFFECTS OF IBOGAINE ON MORPHINE SELF-ADMINISTRATION IN RATS [J].
GLICK, SD ;
ROSSMAN, K ;
STEINDORF, S ;
MAISONNEUVE, IM ;
CARLSON, JN .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 195 (03) :341-345
[9]   LOCAL-EFFECTS OF IBOGAINE ON EXTRACELLULAR LEVELS OF DOPAMINE AND ITS METABOLITES IN NUCLEUS-ACCUMBENS AND STRIATUM - INTERACTIONS WITH D-AMPHETAMINE [J].
GLICK, SD ;
ROSSMAN, K ;
WANG, S ;
DONG, N ;
KELLER, RW .
BRAIN RESEARCH, 1993, 628 (1-2) :201-208
[10]   ACUTE AND PROLONGED EFFECTS OF IBOGAINE ON BRAIN DOPAMINE METABOLISM AND MORPHINE-INDUCED LOCOMOTOR-ACTIVITY IN RATS [J].
MAISONNEUVE, IM ;
ROSSMAN, KL ;
KELLER, RW ;
GLICK, SD .
BRAIN RESEARCH, 1992, 575 (01) :69-73